These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1094642)

  • 21. Optimal dose of methylprednisolone during renal hypothermic pulsatile perfusion.
    Toledo-Pereyra LH; Oh HK; Dienst SG
    Transplantation; 1978 Jun; 25(6):342-3. PubMed ID: 351895
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide.
    Kiberd BA; Young ID
    J Lab Clin Med; 1994 Oct; 124(4):496-506. PubMed ID: 7930875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor pretreatment with cyclophosphamide and methylprednisolone.
    Brom HL; van Breda Vriesman PJ
    Transplantation; 1983 Jul; 36(1):106-7. PubMed ID: 6408773
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized prospective study of cadaver donor pretreatment in renal transplantation.
    Jeffery JR; Downs A; Grahame JW; Lye C; Ramsey E; Thomson AE
    Transplantation; 1978 Jun; 25(6):287-9. PubMed ID: 351886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination drug treatment in immunosuppression. Effect of azathioprine, cyclophosphamide, and methylprednisolone on rabbit renal allografts.
    Friedman EA; Ueno A; Beyr MM; Nicastri AD
    Transplantation; 1973 Jun; 15(6):619-23. PubMed ID: 4577157
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppression with cyclophosphamide in the dog.
    Putnam CW; Halgrimson CG; Groth CG; Kashiwagi N; Porter KA; Starzl TE
    Clin Exp Immunol; 1975 Nov; 22(2):323-9. PubMed ID: 765024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment of cadaver donors with cyclophosphamide and methylprednisolone: effect on renal transplant outcome.
    Corry RJ; Patel NP; West JC; Schanbacher BA
    Transplant Proc; 1980 Jun; 12(2):348-51. PubMed ID: 6994305
    [No Abstract]   [Full Text] [Related]  

  • 28. Steroid-cyclophosphamide pretreatment of kidney allograft donors. A control study.
    Soulillou JP; Baron D; Rouxel A; Guenel J
    Nephron; 1979; 24(4):193-7. PubMed ID: 386157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.
    McCabe R; Swistel A; Lorieo D; Fitzpatrick HF
    Transplant Proc; 1980 Jun; 12(2):355-7. PubMed ID: 6156529
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ultrastructure of canine renal homografts glomerular and interstitial changes of non-immunosuppressive group].
    Tokue A
    Nihon Hinyokika Gakkai Zasshi; 1971 Sep; 62(9):661-78. PubMed ID: 4937304
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimal management of warm ischemic kidneys prior to hypothermic preservation.
    Toledo-Pereyra LH; Moberg AW; Najarian JS
    Transplant Proc; 1974 Sep; 6(3):279-82. PubMed ID: 4606875
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary cadaver kidney transplant survival after donor pretreatment with cyclophosphamide and methylprednisolone.
    Barry JM; Bennett WM
    Transplantation; 1978 Sep; 26(3):202-3. PubMed ID: 360520
    [No Abstract]   [Full Text] [Related]  

  • 33. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD; Morehouse DD; Meakins JL; Klassen J; Knaack J; Beaudoin JG
    Kidney Int Suppl; 1978 Jun; (8):S99-102. PubMed ID: 357821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune injury from organ preservation. A potential cause of hyperacute rejection in human cadaver kidney transplantation.
    Light JA; Annable C; Perloff LJ; Sulkin MD; Hill GS; Etheredge EE; Spees EK
    Transplantation; 1975 Jun; 19(6):511-6. PubMed ID: 124487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intimal injuries in vessels of the preserved kidney.
    Sasaki T; Nakano Y; Miyata Y; Goto K; Okazaki H; Tsutsumi E; Taguchi Y; Kasai M
    Transplant Proc; 1979 Mar; 11(1):465-8. PubMed ID: 377677
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined effect of recipient blood transfusion and donor pretreatment with cyclophosphamide and methylprednisolone.
    Corry RJ; West JC
    Transplant Proc; 1981 Mar; 13(1 Pt 1):161-3. PubMed ID: 7022814
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro alteration of canine renal allograft immunogenicity.
    Waltzer WC; Zincke H; Sterioff S; Holley KE; Offord KP; Matsuura JK
    Transplantation; 1980 Mar; 29(3):249-51. PubMed ID: 6987791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological alterations in perfused,preserved and reinserted renal autotransplants.
    Weber HW; van Zyl JJ; Murphy GP
    S Afr Med J; 1968 Aug; ():Suppl:79-83. PubMed ID: 4175638
    [No Abstract]   [Full Text] [Related]  

  • 39. Attempted antigenic alteration of canine kidneys by 24- or 48-hr perfusion with immunosuppressive agents.
    Woods JE; Cooperman AM; Holley KE
    Transplantation; 1972 Mar; 13(3):336. PubMed ID: 4553735
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimal perfusion parameters in kidney preservation.
    Vrubel J; Nozicková M; Hahn M; Ondrácek Z
    Czech Med; 1978; 1(2):104-10. PubMed ID: 359280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.